Abstract
Abstract Micronised mebendazole has been shown to have anthelmintic activity against Fasciola hepatica in rats and sheep. Activity is higher against non-egg-producing F. hepatica in bile ducts than against the migrating larval stages. Parbendazole, cambendazole and thiabendazole have been shown to be much less active, or devoid of activity, against mature and immature F. hepatica in rats, at elevated dose rates. Reasons for the differences, in terms of molecular structure, are briefly discussed and the pitfalls of structure/activity analyses are considered.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
